KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Asset Writedowns and ImpairmentAsset Writedowns and ImpairmentCapital ExpendituresCapital ExpendituresCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in Account PayablesChange in Account PayablesChange in Accured ExpensesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in InventoryChange in ReceivablesChange in ReceivablesDepreciation & Amortization (CF)Depreciation & Amortization (CF)Depreciation and DepletionDepreciation and DepletionExchange Rate EffectExchange Rate EffectFree Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesLong-Term Debt IssuancesNet Cash FlowNet Cash FlowNet IncomeShare-based CompensationShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Twist Bioscience (TWST) Cash from Financing Activities (2017 - 2026)

Twist Bioscience has reported Cash from Financing Activities over the past 10 years, most recently at $4.1 million for Q1 2026.

  • Quarterly Cash from Financing Activities rose 29.47% to $4.1 million in Q1 2026 from the year-ago period, while the trailing twelve-month figure was $11.8 million through Mar 2026, down 57.23% year-over-year, with the annual reading at $28.5 million for FY2025, 314.22% up from the prior year.
  • Cash from Financing Activities was $4.1 million for Q1 2026 at Twist Bioscience, up from $298000.0 in the prior quarter.
  • Over five years, Cash from Financing Activities peaked at $271.6 million in Q1 2022 and troughed at -$1.5 million in Q4 2023.
  • The 5-year median for Cash from Financing Activities is $1.8 million (2025), against an average of $18.4 million.
  • Year-over-year, Cash from Financing Activities soared 18619.23% in 2022 and then tumbled 272.91% in 2023.
  • A 5-year view of Cash from Financing Activities shows it stood at -$395000.0 in 2022, then tumbled by 272.91% to -$1.5 million in 2023, then soared by 1318.19% to $17.9 million in 2024, then tumbled by 98.34% to $298000.0 in 2025, then surged by 1288.59% to $4.1 million in 2026.
  • Per Business Quant, the three most recent readings for TWST's Cash from Financing Activities are $4.1 million (Q1 2026), $298000.0 (Q4 2025), and $5.6 million (Q3 2025).